Preferred Label : Gamifant;
Origin ID : M000666015;
Related record
https://www.ema.europa.eu/en/medicines/human/EPAR/gamifant
2021
false
false
false
Netherlands
French
English
treatment outcome
Emapalumab
antibodies, neutralizing
antibodies, monoclonal
syndication feed
summary of product characteristics
package leaflet
drug evaluation
child
adolescent
lymphohistiocytosis, hemophagocytic
familial hemophagocytic lymphocytosis
infusions, intravenous
orphan drug production
emapalumab
europe
Gamifant
Emapalumab
---
